Eyegate Pharmaceuticals Inc Warrants 2015-2020 On Shs
(NASDAQ : EYEGW)

( )
EYEGW After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
ICPTIntercept Pharmaceuticals, Inc.
-7.27%91.8318.6%$115.61m
AMRNAmarin Corporation Plc Sponsored ADR
1.34%17.432.0%$110.08m
SAGESAGE Therapeutics, Inc.
-1.00%146.189.5%$75.87m
JAZZJazz Pharmaceuticals Plc
-1.24%125.212.2%$72.29m
PRGOPerrigo Co. Plc
-1.29%48.316.8%$61.64m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-1.32%143.956.3%$58.83m
CTLTCatalent Inc
-0.54%42.562.4%$43.41m
PTLAPortola Pharmaceuticals, Inc.
0.67%30.157.7%$42.79m
ICLRICON Plc
-2.58%142.154.1%$34.10m
UTHRUnited Therapeutics Corporation
-0.74%117.0214.4%$30.49m
HZNPHorizon Pharma plc
-1.39%21.247.4%$29.47m
CORTCorcept Therapeutics Incorporated.
-2.03%11.095.5%$29.29m
MDCOMedicines Company
0.04%23.9021.8%$27.19m
AERIAerie Pharmaceuticals, Inc.
-2.30%38.706.9%$25.97m
IRWDIronwood Pharmaceuticals, Inc. Class A
-0.84%14.1810.1%$24.42m

Company Profile

EyeGate Pharma is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes EGP-437 and Ocular Bandage Gel (OBG). OBG is a topically-applied eye drop formulation that is being developed under the 510k De Novo path for devices submitted for marketing clearance to the U.S. FDA. The company was founded in 1998 and is headquartered in Waltham, MA.